Cambridge Cancer Genomics

Cambridge Cancer Genomics (CCG.ai)'s mission is to ensure that every patient has the right drug at the right time to overcome their cancer. Cambridge Cancer Genomics builds software to enable data-driven precision oncology and systematically develops data-driven biomarkers that indicate treatment response. It believes that the growing amount of clinical and genomic data has the potential to transform cancer care, empowering oncologists to make more informed decisions about which drug to use in which situation.